Embryonic stem cell-based therapies discriminate: they only cure Europeans
Human embryonic stem cells are a revolutionary and easily accessible tool for the treatment of many diseases which remain difficult to cure. We hear such statements quite often. But new international research involving the team of Petr Dvořák of the Department of Biology of Masaryk University's Faculty of Medicine now says that researchers have not yet reached a full understanding of the genetic diversity of embryonic stem cells. Information about this diversity is necessary for the wide application of stem cell-based therapies.